Tracon Pharmaceutical IPO Research Information

Tracon Pharmaceutical IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tracon Pharmaceutical , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tracon Pharmaceutical	TCON - NASDAQ	$12.00-$14.00	$10.00	$10.00	3.6 million	1/30/2015
Underwriter(s): Wells Fargo Securities, Stifel
Co-Manager(s): Needham & Company, Oppenheimer & Co.
Industry: Health Care
Filing(s): Filed 2014-12-29 Terms Added 2015-01-20

Tracon Pharmaceutical Quote & Chart - Click for current quote - TCON

About Tracon Pharmaceutical (adapted from Tracon Pharmaceutical prospectus):
They are a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration, or AMD, and fibrotic diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "TCON" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.